Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: Inverse correlation between expression and tumor progression

Leukemia Research

Volumn 20, Issue 10, 1996, Pages 839-851

  Khaldoyanidi, Sophia ^a   Achtnich, Martin ^b   Hehlmann, Rüdiger ^b   Zöller, Margot ^a,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

CD44 variant isoforms; Non Hodgkin's lymphoma

Indexed keywords

HERMES ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; EXON; FEMALE; HEMATOLOGIC DISEASE; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKEMIA; LEUKOCYTE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PHENOTYPE; POLYCYTHEMIA VERA; PRIORITY JOURNAL; SURVIVAL TIME; T LYMPHOCYTE; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LEUKEMIA; LYMPHOCYTES; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; NEOPLASM STAGING;

EID: 0030272711     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00048-3     Document Type: Article

References (70)

1. 1. Jalkanen S., Bargatze R. F., Toyos J. de los & Butcher E. C. (1986) A lymphoid cell surface protein involved in endothelial cell recognition, and lymphocyte homing in man. Eur. J. Immunol. 16, 1195.
2. 2. Goldstein L. A., Zhou D. F. H., Picker L. J., Minty C. N., Bargatze R. F., Ding J. F. & Butcher E. C. (1989) A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core, and link proteins. Cell 56, 1063.
3. 3. Zhou D. F. H., Ding J. F., Picker L. F., Bargatze R. F., Butcher E. C. & Goeddel D. V. (1989) Molecular cloning, and expression of Pgp-1 - The mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. J. Immunol. 143, 3390.
4. 4. Idzerda R. L., Carter W. G., Nottenburg C., Wayner E. A., Gallatin W. M. & St John T. (1989) Isolation, and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium. Proc. natn. Acad. Sci. U.S.A. 86, 4659.
5. 5. Stamenkovic I., Amiot M., Pesando J. M. & Seed B. (1989) A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56, 1057.
6. 6. Berg P. V., Goldstein L. A., Jutila M. A., Nakache M., Picker L. P., Streeter P. R., Wu N. W., Zhou D. & Butcher E. C. (1989) Homing receptors, and vascular addressins: cell adhesion molecules that direct lymphocyte traffic. Immunol. Rev. 108, 5.
7. 7. Jalkanen S., Jalkanen M., Bargatze R., Tammi M. & Butcher E. C. (1988) Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol. 141, 1615.
8. 8. Budd R. C., Cerottini J. C. & MacDonald H. R. (1987) Selectively increased production of interferon-α by subsets of Lyt-2+, and L3T4+ T cells identified by expression of Pgp-1. J. Immunol. 138, 3586.
9. 9. Huet S., Groux H., Caillou B., Valentin H., Prieur A. M. & Bernard A. (1989) CD44 contributes to T cell activation. J. Immunol. 143, 798.
10. 10. Shimizu Y., Seventer G. A. van, Siraganian R., Wahl L. & Shaw S. (1989) Dual role of the CD44 molecule in T-cell adhesion, and activation. J. Immunol. 143, 2457.
11. 11. Denning S. M., Le P. T., Singer K. H. & Haynes B. F. (1990) Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J. Immunol. 144, 7.
12. 12. Murakami S., Miyake K., June C. H., Kincade P. W. & Hodes R. J. (1990) IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity, and binds to hyaluronate. J. Immunol. 145, 3618.
13. 13. Rothman B. L., Blue M. L., Kelley K. A., Wunderlich D., Mierz D. V. & Aune T. M. (1991) Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44. J. Immunol. 147, 2493.
14. 14. Seth A., Gote L., Nagarkatti M. & Nagarkatti P. S. (1991) T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44, and gp90MEL-14. Proc. natn. Acad. Sci. U.S.A. 88, 7877.
15. 15. Pierres A., Lipcey C., Mawas C. & Olive D. (1992) A unique CD44 monoclonal antibody identifies a new T cell activation pathway. Eur. J. Immunol. 22, 413.
16. 16. Tan P. H., Santos E. B., Rossbach H. C. & Sandmaier B. M. (1993) Enhancement of natural killer activity by an antibody to CD44. J. Immunol. 150, 812.
17. 17. Galandrini R., Albi N., Tripodi G., Zarcone D., Terenzi A., Moretta A., Grossi C. E. & Velardi A. (1993) Antibodies to CD44 trigger effector functions of human T cell clones. J. Immunol. 150, 4225.
18. 18. Funaro A., Spagnoli G. C., Momo M., Knapp W. & Malavasi F. (1994) Stimulation of T cells via CD44 requires LFA-1 interactions, and IL-2 production. Human Immunol. 40, 267.
19. 19. Camp R. L., Scheynius A., Johansson C. & Pure E. (1993) CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J. exp. Med. 178, 497.
20. 20. Horst E., Meijer C. J., Duijvestijn A. M., Hartwig N., Van der Harten H. J. & Pals S. T. (1990) The ontogeny of human lymphocyte recirculation: high endothelial cell antigen (HECA-452), and CD44 homing receptor expression in the development of the immune system. Eur. J. Immunol. 20, 1483.
21. 21. Collado A., DeAndres A., Canadas E., Ruiz-Cabello F., Gomez O., Pedrinaci S. & Garrido F. (1991) Characterization of CD44 antigen during lymphoid ontogeny. Immunobiology 183, 1.
22. 22. Miyake K., Medina K. L., Hayashi S. I., Ono S., Hamaoka T. & Kincade P. W. (1990) Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. exp. Med. 171, 477.
23. 23. Kansas G. S. & Dailey M. O. (1989) Expression of adhesion structures during B cell development in man. J. Immunol. 142, 3058.
24. 24. Kincade P. W., He Q., Ishihara K., Miyake K., Lesley J. & Hyman R. (1993) CD44, and other cell interaction molecules contributing to B lymphopoiesis. Curr. Top. Microbiol. Immunol. 184, 215.
25. 25. Morimoto K., Robin E., LeBousse-Kerdiles M. C., Li Y., Clay D., Jasmin C. & Smadja-Joffe F. (1994) CD44 mediates hyaluronan binding by human myeloid KG1A, and KG1 cells. Blood 1, 657.
26. 26. Lewinsohn D. M., Nagler A., Ginzton N., Greenberg P. & Butcher E. C. (1990) Hematopoietic progenitor cell expression of the H-Cam (CD44) homing-associated adhesion molecule. Blood 75, 589.
27. 27. Lund-Johansen F. & Terstappen L. W. (1993) Differential surface expression of cell adhesion molecules during granulocyte maturation. J. Leukoc. Biol. 54, 47.
28. 28. Kansas G. S., Muirhead M. J. & Dailey M. O. (1990) Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid, and erythroid differentiation in humans. Blood 76, 2483.
29. 29. Sandmaier B. M., Storb R., Appelbaum F. R. & Gallatin W. M. (1990) An antibody that facilitates hematopoetic engraftment recognizes CD44. Blood 76, 630.
30. 30. Goldstein L. A. & Butcher E. C. (1990) Identification of mRNA that encodes an alternative form of H-CAM (CD44) in lymphoid, and nonlymphoid tissues. Immunogenetics 32, 389.
31. 31. Stamenkovic L., Aruffo A., Amiot M. & Seed B. (1991) The hematopoietic, and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J. 10, 343.
32. 32. Dougherty G. J., Lansdorp P. M., Cooper D. L. & Humphries R. K. (1991) Molecular cloning of CD44R1, and CD44R2, two novel isoforms of the human CD44 lymphocyte 'homing' receptor expressed by hemopoietic cells. J. exp. Med. 174, 1.
33. 33. Screaton G. R., Bell M. V., Jackson D. G., Cornelis F. B., Gerth U. & Bell J. I. (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. natn. Acad. Sci. U.S.A. 89, 12160.
34. 34. Tölg C., Hofmann M., Herrlich P. & Ponta H. (1993) Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21, 1225.
35. 35. Günthert U., Hofmann M., Rudy W., Reber S., Zöller M., Haussmann I., Matzku S., Wenzel A., Ponta H. & Herrlich P. (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65, 13.
36. 36. Chaudhry A., Gobl A., Eriksson B., Skogseid B. & Oberg K. (1994) Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors. Cancer Res. 54, 981.
37. 36a. Seiter S., Herrmann K., Möller P., Patzelt E., Tilgen W. & Zöller M. (1996) Expression of splice variant of CD44 on human skin and epidermal tumours. Virchow's Archiv Pathol. 428, 141.
38. 37. Salmi M., Gron-Virta K., Sointu P., Grenman R., Kalimo H. & Jalkanen S. (1993) Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J. Cell Biol. 122, 431.
39. 37a. Herold-Mende C., Seiter S., Jourdan U., Herrmann K., Born Al., Patzelt E., Zöller J., Bosch F. X. & Zöller M., (1996) Expression of splice variants of CD44 on squamous epithelia and squamous cell carcinoma of head and neck. J. Pathol. 179, 66.
40. 38. Zöller M. & Kaufmann M. (1994) CD44, and metastasis. Onkologie 17, 114.
41. 39. Fox S. B., Gatter K. C., Jackson D. G., Screaton G. R., Bell M. V., Bell J. I., Harris A. L., Simmons D. & Fawcett J. (1993) CD44 and cancer screening. Lancet 342, 548.
42. 40. Günthert U., Stauder R., Mayer B., Terpe H. J., Finke L. & Friedrichs K. (1995) Are CD44 variant isoforms involved in human tumor progression. Cancer Surveys 24, 19.
43. 41. Matsumara Y. & Tarin D. (1993) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340, 1053.
44. 42. Tanabe K. K. & Saya H. (1994) The CD44 adhesion molecule and metastasis. Crit. Rev. Oncogenesis 5, 2.
45. 43. Cooper D. L. & Dougherty G. J. (1995) To metastasize or not? Selection of CD44 splice sites. Nature Med. 1, 635.
46. 44. Wielenga V. J. M., Heider K. H., Offerhaus J. A., Adolf G. R., Berg F. M. van den, Ponta H., Herrlich P. & Pals S. T. (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 53, 4754.
47. 45. Kaufmann M., Heider K. H., Sinn H. P., Minckwitz G. von, Ponta H. & Herrlich P. (1995) CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345, 615.
48. 46. Stauder R., Eisterer W., Thaler J. & Günthert U. (1995) CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor. Blood 15, 85.
49. 47. Ristamäki R., Joensuu H., Söderström K. O. & Jalkanen S. (1995) CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis. J. Pathol. 176, 259.
50. 48. Pals S. T., Horst E., Ossekoppele G. J., Figdor C. G., Scheper R. J. & Meijer C. J. L. M. (1989) Expression of lymphocyte homing receptor (CD44) as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood 73, 885.
51. 49. Horst E., Meijer C. J. L. M., Radaszkiewicz T., Ossekoppele G. J., Van Krieken J. H. J. M. & Pals S. T. (1990) Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Leukemia 4, 595.
52. 50. Jalkanen S., Joensuu H. & Klemi P. (1990) Prognostic value of lymphocyte homing receptor, and, and S values in non-Hodkin's lymphoma. Blood 75, 1549.
53. 51. Sy M. S., Guo Y. I. & Stamenkovic I. (1991) Distinct effects of two CD44 isoforms on tumor growth in vivo. J. exp. Med. 174, 859.
54. 52. Jalkanen S., Joensuu H., Söderström K. O. & Klemi P. (1991) Lymphocyte homing, and clinical behavior of non-Hodgkin's lymphoma. J. clin. Invest. 87, 1835.
55. 53. Koopman G., Heider K. H., Horst E., Adolf G. R., Berg F. van den, Ponta H., Herrlich P. & Pals S. T. (1993) Activated human lymphocytes, and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. exp. Med. 177, 897.
56. 54. Ey P. L., Prowse S. J. & Jenkin C. R. (1978) Isolation of pure IgG1, IgG2a, and IgG2b immunoglobulins from mouse serum using protein A-Sepharose. Immunochemistry 15, 429.
57. 55. Björck L. & Kronvall G. (1984) Purification, and some properties of streptococcal Protein G: a novel IgG binding reagent. J. Immunol. 133, 969.
58. 56. Stansfeld A. G., Diebold J., Noel H., Kapanci Y., Rilke F., Kelenyi G., Sundström C., Lennert K., Unnik J. A. M. van, Mioduszewska O. & Wright D. H. (1988) Updated Kiel classification for lymphomas. Lancet i, 292.
59. 57. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W. & Tubiana M. (1971) Report of the committee on Hodgkin's disease staging classification. Cancer Res. 31, 1860.
60. 58. Arch R., Wirth K., Hofmann M., Ponta H., Matzku S., Herrlich P. & Zöller M. (1992) Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257, 682.
61. 59. Salles G., Zain M., Jiang W. M., Boussiotis V. A. & Shipp M. A. (1993) Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: characterizatiom, and comparison with normal activated B cells, and epithelial malignancies. Blood 82, 3539.
62. 60. Mackay C. R., Terpe H. J., Stauder R., Marston W. L., Stark H. & Günthert U. (1994) Expression, and modulation of CD44 variant isoforms in humans. J. Cell Biol. 124, 71.
63. 61. Ristamäki R., Joensuu H., Salmi M. & Jalkanen S. (1994) Serum CD44 in malignant lymphoma: an association with treatment response. Blood 84, 238.
64. 62. Seiter S., Arch R., Reber S., Komitowski D., Hofmann M., Ponta H., Herrlich P., Matzku S. & Zöller M. (1993) Prevention of tumor metastasis formation by anti-variant CD44. J. exp. Med. 177, 443.
65. 63. Zöller M. (1994) Function of variant isoforms of CD44 in lymphocyte activation, and lymphatic spread of tumor cells. In Topics in Molecular Medicine (Siess W., Lorenz R. & Weber P.C., Eds), p. 201. Raven Press, New York.
66. 64. Haynes B. F., Liao H. X. & Patton K. L. (1991) The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 3, 347.
67. 65. Günthert U. (1993) CD44: a multitude of isoforms with diverse functions. Curr. Top. Microbiol. Immunol. 184, 47.
68. 66. Wirth K., Arch R., Somasundaram C., Hofmann M., Weber B., Herrlich P., Matzku S. & Zöller M. (1993) Expression of CD44 isoforms carrying metastasis-associated sequences in newborn, and adult rats. Eur. J. Cancer 29, 1172.
69. 67. Wheatley S. C., Isacke C. M. & Crossley P. H. (1993) Restricted expression of the hyaluronan receptor, CD44, during postimplantation mouse embryogenesis suggests key roles in tissue formation, and patterning. Development 119, 295.
70. 68. Fox S. B., Fawcett J., Jackson D. G., Collins I., Gatter K. C., Harris A. L., Gearing A. & Simmons D. L. (1994) Normal human tissues, in addition to tumours, express multiple different CD44 isoforms. Cancer Res. 54, 4539.